Yes the trial itself was a failure only due to design delivering a false negative. They tried to recruit more participants to give the statistics more power and make them more reliable but clearly not enough. The problem I have with cometary here is people trying to portray Viraleze itself as a failure. It is far from that. Read the comments from the scientific community involved in the study. Very impressed and positive feedback.
Yes the trial itself was a failure only due to design delivering...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $70.99K | 620.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 337138 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 116759 | 6 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 11.5¢ | 11.0¢ | 165069 | ||
| Last updated 15.30pm 17/05/2024 ? | |||||
| SPL (ASX) Chart |